Get started
Author

Kyle Smith

OpenAlex ID: A5128884209
ID #585 Minimally invasive detection of extrachromosomal DNA in cerebrospinal fluid from medulloblastoma patients
2026 · Ryan Tian, Brent Orr, et al. · Neuro-Oncology Pediatrics
ID #860 AI-based Precision Prognostics and Therapy Personalization for Childhood Brain Tumors
2026 · Sabina Stefan, Amelie Amann, et al. · Neuro-Oncology Pediatrics
ID #215 Single-cell DNA methylation profiling reveals genetic and epigenetic tumor evolution in medulloblastoma
2026 · Ida Larsson, Vincentius Martin, et al. · Neuro-Oncology Pediatrics
ID #322 Trans-species analysis of the unique immunobiology of DNA replication-repair deficient (RRD) medulloblastoma translates to novel therapeutic approaches: an IRRDC report
2026 · Anirban Das, Nicholas Fernandez, et al. · Neuro-Oncology Pediatrics
MDB-29. Humanized iPSC models for group 3 medulloblastoma reveal key context-specific functions for MYC in remodeling the chromatin landscape.
2025 · Zulekha Qadeer, Dara Siegel, et al. · Neuro-Oncology Pediatrics
MDB-24. Integrated metabolic and epigenetic therapies for Group-3 Medulloblastomas
2025 · Derek Dang, Akash Deogharkar, et al. · Neuro-Oncology Pediatrics
PATH-03. AI-based Precision Prognostics and Therapy Personalization for Pediatric Brain Tumors
2025 · Sabina Stefan, Amelie Amann, et al. · Neuro-Oncology Pediatrics
Works count: 7
Citation count:
H-index:
I10-index:
Year
Topic
Type